Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Fanci
R
R
Department of Hematology, Careggi Hospital and University of Florence, Italy. r.fanci@dac.unifi.it
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002175:Candida; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D000077336:Caspofungin; D055499:Catheter-Related Infections / Q000150:complications / Q000188:drug therapy; D003428:Cross Infection / Q000150:complications / Q000188:drug therapy; D054714:Echinocandins / Q000627:therapeutic use*; D016469:Fungemia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D055666:Lipopeptides; D008297:Male; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D011743:Pyrimidines; D014230:Triazoles; D000077336:Caspofungin; D065819:Voriconazole